Does administration of oral versus intravenous antibiotics for third molar removal have an effect on the incidence of alveolar osteitis or postoperative surgical site infections?
Abstract Purpose To compare the incidence of postoperative alveolar osteitis (AO) and surgical site infections (SSI) among two separate cohorts of subjects undergoing elective third molar removal: those that received postoperative oral (PO) antibiotics and those that received perioperative intraveno...
Gespeichert in:
| Veröffentlicht in: | Journal of oral and maxillofacial surgery 2017-09, Vol.75 (9), p.1801-1808 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1808 |
|---|---|
| container_issue | 9 |
| container_start_page | 1801 |
| container_title | Journal of oral and maxillofacial surgery |
| container_volume | 75 |
| creator | Reiland, Matthew D., DDS, MD Ettinger, Kyle S., DDS, MD Lohse, Christine M., MS Viozzi, Christopher F., DDS, MD |
| description | Abstract Purpose To compare the incidence of postoperative alveolar osteitis (AO) and surgical site infections (SSI) among two separate cohorts of subjects undergoing elective third molar removal: those that received postoperative oral (PO) antibiotics and those that received perioperative intravenous (IV) antibiotics. Materials and Methods A retrospective cohort study of all subjects aged 14 to 30 undergoing elective outpatient third molar removal under a single surgeon’s service over a 12-year period was completed. Subjects undergoing third molar removal during the first 72 months received postoperative PO antibiotics alone. Subjects undergoing third molar removal during the second 72 months received perioperative IV antibiotics alone. The primary predictor variable for the study was the antibiotic regimen employed at the time of third molar removal. The primary outcome variable was the postoperative development of AO or SSI. Covariates included age and gender. Univariable and multivariable regression models assessed for associations between the antibiotic regimen employed and the presence of AO and SSI. Results The study sample consisted of 1895 subjects (1020 subjects receiving postoperative PO antibiotics and 875 subjects receiving perioperative IV antibiotics). Among subjects receiving postoperative PO antibiotics, 6.4% developed AO an average of 5.7 days following the procedure and 2.6% developed SSI an average of 23.2 days following the procedure. Among subjects receiving perioperative IV antibiotics, 5.5% developed AO an average of 6.2 days following the procedure and 3.3% developed SSI an average of 18.2 days following the procedure. No statistically significant associations between the antibiotic regimen employed and the presence of AO or SSI were identified in either univariable or multivariable analyses. Among the postoperative PO antibiotic cohort, older age (p |
| doi_str_mv | 10.1016/j.joms.2017.03.038 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1891888234</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0278239117303567</els_id><sourcerecordid>1891888234</sourcerecordid><originalsourceid>FETCH-LOGICAL-c521t-e402521b9f3f55e40baed48aac93e97954c294f9596353ebc457bce95f4a82243</originalsourceid><addsrcrecordid>eNp9ks2O0zAUhSMEYsrAC7BAXrJp8U_c2BICjYZfaSQWwNpynBvqksTF1600r8UTck0HFiyQLNmWz_ninOOmeSr4RnCxfbHf7NOMG8lFt-GKhrnXrIRWYq25VvebFZedWUtlxUXzCHHPuRC62z5sLqRpldFWr5qfbxIg88Mcl4gl-xLTwtLIUvYTO0HGI7K40MEJlkRrv5TYx1RiQDamzMou5oHNafKZZZjTiWw7EpOQwThCKIyAZQdECXGAJUDF--kEvz0JC8QSkT7IDrRJB6iXIAAe87cYCIexVHdl0eXw9ePmwegnhCd382Xz9d3bL9cf1jef3n-8vrpZBy1FWUPLJS16O6pRa9r1HobWeB-sAttZ3QZp29Fqu1VaQR9a3fUBrB5bb6Rs1WXz_Mw95PTjCFjcHDHANPkFKAonjBXGGKmqVJ6lISfEDKM75Dj7fOsEd7Urt3e1K1e7clzRMGR6dsc_9jMMfy1_yiHBy7MA6C9PEbLDEGuCQ8wUhhtS_D__1T_2MFHLFOl3uAXcp2NeKD8nHErH3ef6WupjEZ3iSm879Quptr-a</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1891888234</pqid></control><display><type>article</type><title>Does administration of oral versus intravenous antibiotics for third molar removal have an effect on the incidence of alveolar osteitis or postoperative surgical site infections?</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Reiland, Matthew D., DDS, MD ; Ettinger, Kyle S., DDS, MD ; Lohse, Christine M., MS ; Viozzi, Christopher F., DDS, MD</creator><creatorcontrib>Reiland, Matthew D., DDS, MD ; Ettinger, Kyle S., DDS, MD ; Lohse, Christine M., MS ; Viozzi, Christopher F., DDS, MD</creatorcontrib><description>Abstract Purpose To compare the incidence of postoperative alveolar osteitis (AO) and surgical site infections (SSI) among two separate cohorts of subjects undergoing elective third molar removal: those that received postoperative oral (PO) antibiotics and those that received perioperative intravenous (IV) antibiotics. Materials and Methods A retrospective cohort study of all subjects aged 14 to 30 undergoing elective outpatient third molar removal under a single surgeon’s service over a 12-year period was completed. Subjects undergoing third molar removal during the first 72 months received postoperative PO antibiotics alone. Subjects undergoing third molar removal during the second 72 months received perioperative IV antibiotics alone. The primary predictor variable for the study was the antibiotic regimen employed at the time of third molar removal. The primary outcome variable was the postoperative development of AO or SSI. Covariates included age and gender. Univariable and multivariable regression models assessed for associations between the antibiotic regimen employed and the presence of AO and SSI. Results The study sample consisted of 1895 subjects (1020 subjects receiving postoperative PO antibiotics and 875 subjects receiving perioperative IV antibiotics). Among subjects receiving postoperative PO antibiotics, 6.4% developed AO an average of 5.7 days following the procedure and 2.6% developed SSI an average of 23.2 days following the procedure. Among subjects receiving perioperative IV antibiotics, 5.5% developed AO an average of 6.2 days following the procedure and 3.3% developed SSI an average of 18.2 days following the procedure. No statistically significant associations between the antibiotic regimen employed and the presence of AO or SSI were identified in either univariable or multivariable analyses. Among the postoperative PO antibiotic cohort, older age (p<0.001) and female gender (p<0.001) were significantly associated with the development of AO, and female gender (p=0.015) was significantly associated with the presence of SSI. Among the perioperative IV antibiotic cohort, female gender was significantly associated with the development of AO (p=0.011), and younger age was significantly associated with the presence of SSI (p=0.011). Conclusion The use of a postoperative PO antibiotic regimen versus perioperative IV antibiotic regimen does not significantly alter the incidence of AO or SSI following elective third molar removal. We conclude that if the surgeon chooses to use antibiotics in the setting of third molar surgery, perioperative IV antibiotics are preferable over postoperative PO antibiotics, as they obviate any issues with patient compliance and may be less costly.</description><identifier>ISSN: 0278-2391</identifier><identifier>EISSN: 1531-5053</identifier><identifier>DOI: 10.1016/j.joms.2017.03.038</identifier><identifier>PMID: 28438595</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Administration, Oral ; Adolescent ; Adult ; Anti-Bacterial Agents - administration & dosage ; Antibiotic Prophylaxis ; Dentistry ; Dry Socket - epidemiology ; Dry Socket - prevention & control ; Female ; Humans ; Incidence ; Injections, Intravenous ; Male ; Minnesota - epidemiology ; Molar, Third - surgery ; Retrospective Studies ; Surgery ; Surgical Wound Infection - epidemiology ; Surgical Wound Infection - prevention & control ; Tooth Extraction ; Treatment Outcome</subject><ispartof>Journal of oral and maxillofacial surgery, 2017-09, Vol.75 (9), p.1801-1808</ispartof><rights>2017 American Association of Oral and Maxillofacial Surgeons</rights><rights>Copyright © 2017 American Association of Oral and Maxillofacial Surgeons. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c521t-e402521b9f3f55e40baed48aac93e97954c294f9596353ebc457bce95f4a82243</citedby><cites>FETCH-LOGICAL-c521t-e402521b9f3f55e40baed48aac93e97954c294f9596353ebc457bce95f4a82243</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.joms.2017.03.038$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3548,27923,27924,45994</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28438595$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Reiland, Matthew D., DDS, MD</creatorcontrib><creatorcontrib>Ettinger, Kyle S., DDS, MD</creatorcontrib><creatorcontrib>Lohse, Christine M., MS</creatorcontrib><creatorcontrib>Viozzi, Christopher F., DDS, MD</creatorcontrib><title>Does administration of oral versus intravenous antibiotics for third molar removal have an effect on the incidence of alveolar osteitis or postoperative surgical site infections?</title><title>Journal of oral and maxillofacial surgery</title><addtitle>J Oral Maxillofac Surg</addtitle><description>Abstract Purpose To compare the incidence of postoperative alveolar osteitis (AO) and surgical site infections (SSI) among two separate cohorts of subjects undergoing elective third molar removal: those that received postoperative oral (PO) antibiotics and those that received perioperative intravenous (IV) antibiotics. Materials and Methods A retrospective cohort study of all subjects aged 14 to 30 undergoing elective outpatient third molar removal under a single surgeon’s service over a 12-year period was completed. Subjects undergoing third molar removal during the first 72 months received postoperative PO antibiotics alone. Subjects undergoing third molar removal during the second 72 months received perioperative IV antibiotics alone. The primary predictor variable for the study was the antibiotic regimen employed at the time of third molar removal. The primary outcome variable was the postoperative development of AO or SSI. Covariates included age and gender. Univariable and multivariable regression models assessed for associations between the antibiotic regimen employed and the presence of AO and SSI. Results The study sample consisted of 1895 subjects (1020 subjects receiving postoperative PO antibiotics and 875 subjects receiving perioperative IV antibiotics). Among subjects receiving postoperative PO antibiotics, 6.4% developed AO an average of 5.7 days following the procedure and 2.6% developed SSI an average of 23.2 days following the procedure. Among subjects receiving perioperative IV antibiotics, 5.5% developed AO an average of 6.2 days following the procedure and 3.3% developed SSI an average of 18.2 days following the procedure. No statistically significant associations between the antibiotic regimen employed and the presence of AO or SSI were identified in either univariable or multivariable analyses. Among the postoperative PO antibiotic cohort, older age (p<0.001) and female gender (p<0.001) were significantly associated with the development of AO, and female gender (p=0.015) was significantly associated with the presence of SSI. Among the perioperative IV antibiotic cohort, female gender was significantly associated with the development of AO (p=0.011), and younger age was significantly associated with the presence of SSI (p=0.011). Conclusion The use of a postoperative PO antibiotic regimen versus perioperative IV antibiotic regimen does not significantly alter the incidence of AO or SSI following elective third molar removal. We conclude that if the surgeon chooses to use antibiotics in the setting of third molar surgery, perioperative IV antibiotics are preferable over postoperative PO antibiotics, as they obviate any issues with patient compliance and may be less costly.</description><subject>Administration, Oral</subject><subject>Adolescent</subject><subject>Adult</subject><subject>Anti-Bacterial Agents - administration & dosage</subject><subject>Antibiotic Prophylaxis</subject><subject>Dentistry</subject><subject>Dry Socket - epidemiology</subject><subject>Dry Socket - prevention & control</subject><subject>Female</subject><subject>Humans</subject><subject>Incidence</subject><subject>Injections, Intravenous</subject><subject>Male</subject><subject>Minnesota - epidemiology</subject><subject>Molar, Third - surgery</subject><subject>Retrospective Studies</subject><subject>Surgery</subject><subject>Surgical Wound Infection - epidemiology</subject><subject>Surgical Wound Infection - prevention & control</subject><subject>Tooth Extraction</subject><subject>Treatment Outcome</subject><issn>0278-2391</issn><issn>1531-5053</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9ks2O0zAUhSMEYsrAC7BAXrJp8U_c2BICjYZfaSQWwNpynBvqksTF1600r8UTck0HFiyQLNmWz_ninOOmeSr4RnCxfbHf7NOMG8lFt-GKhrnXrIRWYq25VvebFZedWUtlxUXzCHHPuRC62z5sLqRpldFWr5qfbxIg88Mcl4gl-xLTwtLIUvYTO0HGI7K40MEJlkRrv5TYx1RiQDamzMou5oHNafKZZZjTiWw7EpOQwThCKIyAZQdECXGAJUDF--kEvz0JC8QSkT7IDrRJB6iXIAAe87cYCIexVHdl0eXw9ePmwegnhCd382Xz9d3bL9cf1jef3n-8vrpZBy1FWUPLJS16O6pRa9r1HobWeB-sAttZ3QZp29Fqu1VaQR9a3fUBrB5bb6Rs1WXz_Mw95PTjCFjcHDHANPkFKAonjBXGGKmqVJ6lISfEDKM75Dj7fOsEd7Urt3e1K1e7clzRMGR6dsc_9jMMfy1_yiHBy7MA6C9PEbLDEGuCQ8wUhhtS_D__1T_2MFHLFOl3uAXcp2NeKD8nHErH3ef6WupjEZ3iSm879Quptr-a</recordid><startdate>20170901</startdate><enddate>20170901</enddate><creator>Reiland, Matthew D., DDS, MD</creator><creator>Ettinger, Kyle S., DDS, MD</creator><creator>Lohse, Christine M., MS</creator><creator>Viozzi, Christopher F., DDS, MD</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20170901</creationdate><title>Does administration of oral versus intravenous antibiotics for third molar removal have an effect on the incidence of alveolar osteitis or postoperative surgical site infections?</title><author>Reiland, Matthew D., DDS, MD ; Ettinger, Kyle S., DDS, MD ; Lohse, Christine M., MS ; Viozzi, Christopher F., DDS, MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c521t-e402521b9f3f55e40baed48aac93e97954c294f9596353ebc457bce95f4a82243</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Administration, Oral</topic><topic>Adolescent</topic><topic>Adult</topic><topic>Anti-Bacterial Agents - administration & dosage</topic><topic>Antibiotic Prophylaxis</topic><topic>Dentistry</topic><topic>Dry Socket - epidemiology</topic><topic>Dry Socket - prevention & control</topic><topic>Female</topic><topic>Humans</topic><topic>Incidence</topic><topic>Injections, Intravenous</topic><topic>Male</topic><topic>Minnesota - epidemiology</topic><topic>Molar, Third - surgery</topic><topic>Retrospective Studies</topic><topic>Surgery</topic><topic>Surgical Wound Infection - epidemiology</topic><topic>Surgical Wound Infection - prevention & control</topic><topic>Tooth Extraction</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Reiland, Matthew D., DDS, MD</creatorcontrib><creatorcontrib>Ettinger, Kyle S., DDS, MD</creatorcontrib><creatorcontrib>Lohse, Christine M., MS</creatorcontrib><creatorcontrib>Viozzi, Christopher F., DDS, MD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of oral and maxillofacial surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Reiland, Matthew D., DDS, MD</au><au>Ettinger, Kyle S., DDS, MD</au><au>Lohse, Christine M., MS</au><au>Viozzi, Christopher F., DDS, MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Does administration of oral versus intravenous antibiotics for third molar removal have an effect on the incidence of alveolar osteitis or postoperative surgical site infections?</atitle><jtitle>Journal of oral and maxillofacial surgery</jtitle><addtitle>J Oral Maxillofac Surg</addtitle><date>2017-09-01</date><risdate>2017</risdate><volume>75</volume><issue>9</issue><spage>1801</spage><epage>1808</epage><pages>1801-1808</pages><issn>0278-2391</issn><eissn>1531-5053</eissn><abstract>Abstract Purpose To compare the incidence of postoperative alveolar osteitis (AO) and surgical site infections (SSI) among two separate cohorts of subjects undergoing elective third molar removal: those that received postoperative oral (PO) antibiotics and those that received perioperative intravenous (IV) antibiotics. Materials and Methods A retrospective cohort study of all subjects aged 14 to 30 undergoing elective outpatient third molar removal under a single surgeon’s service over a 12-year period was completed. Subjects undergoing third molar removal during the first 72 months received postoperative PO antibiotics alone. Subjects undergoing third molar removal during the second 72 months received perioperative IV antibiotics alone. The primary predictor variable for the study was the antibiotic regimen employed at the time of third molar removal. The primary outcome variable was the postoperative development of AO or SSI. Covariates included age and gender. Univariable and multivariable regression models assessed for associations between the antibiotic regimen employed and the presence of AO and SSI. Results The study sample consisted of 1895 subjects (1020 subjects receiving postoperative PO antibiotics and 875 subjects receiving perioperative IV antibiotics). Among subjects receiving postoperative PO antibiotics, 6.4% developed AO an average of 5.7 days following the procedure and 2.6% developed SSI an average of 23.2 days following the procedure. Among subjects receiving perioperative IV antibiotics, 5.5% developed AO an average of 6.2 days following the procedure and 3.3% developed SSI an average of 18.2 days following the procedure. No statistically significant associations between the antibiotic regimen employed and the presence of AO or SSI were identified in either univariable or multivariable analyses. Among the postoperative PO antibiotic cohort, older age (p<0.001) and female gender (p<0.001) were significantly associated with the development of AO, and female gender (p=0.015) was significantly associated with the presence of SSI. Among the perioperative IV antibiotic cohort, female gender was significantly associated with the development of AO (p=0.011), and younger age was significantly associated with the presence of SSI (p=0.011). Conclusion The use of a postoperative PO antibiotic regimen versus perioperative IV antibiotic regimen does not significantly alter the incidence of AO or SSI following elective third molar removal. We conclude that if the surgeon chooses to use antibiotics in the setting of third molar surgery, perioperative IV antibiotics are preferable over postoperative PO antibiotics, as they obviate any issues with patient compliance and may be less costly.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>28438595</pmid><doi>10.1016/j.joms.2017.03.038</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0278-2391 |
| ispartof | Journal of oral and maxillofacial surgery, 2017-09, Vol.75 (9), p.1801-1808 |
| issn | 0278-2391 1531-5053 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1891888234 |
| source | MEDLINE; Elsevier ScienceDirect Journals Complete |
| subjects | Administration, Oral Adolescent Adult Anti-Bacterial Agents - administration & dosage Antibiotic Prophylaxis Dentistry Dry Socket - epidemiology Dry Socket - prevention & control Female Humans Incidence Injections, Intravenous Male Minnesota - epidemiology Molar, Third - surgery Retrospective Studies Surgery Surgical Wound Infection - epidemiology Surgical Wound Infection - prevention & control Tooth Extraction Treatment Outcome |
| title | Does administration of oral versus intravenous antibiotics for third molar removal have an effect on the incidence of alveolar osteitis or postoperative surgical site infections? |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T14%3A04%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Does%20administration%20of%20oral%20versus%20intravenous%20antibiotics%20for%20third%20molar%20removal%20have%20an%20effect%20on%20the%20incidence%20of%20alveolar%20osteitis%20or%20postoperative%20surgical%20site%20infections?&rft.jtitle=Journal%20of%20oral%20and%20maxillofacial%20surgery&rft.au=Reiland,%20Matthew%20D.,%20DDS,%20MD&rft.date=2017-09-01&rft.volume=75&rft.issue=9&rft.spage=1801&rft.epage=1808&rft.pages=1801-1808&rft.issn=0278-2391&rft.eissn=1531-5053&rft_id=info:doi/10.1016/j.joms.2017.03.038&rft_dat=%3Cproquest_cross%3E1891888234%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1891888234&rft_id=info:pmid/28438595&rft_els_id=S0278239117303567&rfr_iscdi=true |